Month: February 2023

The World’s Largest Apheresis Network Serves as a Catalyst to Advance Cell and Gene Therapies

Is The Industry Prepared for Another Year of Rapid Growth? The cell and gene therapy (CGT) industry is expected to grow rapidly for the next 10 years with an increasing proportion of these treatments focused on allogeneic approaches according to industry analysts (Figure 1)1. Several factors are contributing to CGT’s rapid growth, including advances in […]

Written by on February 27, 2023

Navigating the complex world of regulations: How AllCells is changing cell therapy and protecting against product-ending events

The cell therapy market is valued at 15 billion dollars and is set to double in value by 2030. Cell therapy has been instrumental in the development of treatments like CAR-T therapy, which uses the body’s own T cells to fight cancer. The opportunity within cell therapy is significant, targeting common diseases that afflict millions […]

Written by on February 23, 2023